School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, P. R. China.
J Mater Chem B. 2019 Jan 7;7(1):143-149. doi: 10.1039/c8tb02473a. Epub 2018 Dec 6.
To overcome the unfavorable effects of the hydrophobicity of drugs and cancer resistance, mesoporous NiS nanospheres (mNiS NSs) have been successfully developed here to package hydrophobic camptothecin (CPT) and realize the synergistic photothermal-chemotherapy of cancer. The mNiS NSs which were prepared through a facile solvothermal method here exhibited not only considerable near-infrared (NIR) absorption and good photothermal conversion efficiency as high as 44.6%, but also achieved a NIR light induced CPT release property which were both beneficial for improving the cancer cell-killing efficacy. After a short period of NIR light illumination, a significant intensified cell killing efficacy was observed when 4T1 or HepG2 cancer cells were incubated with CPT@mNiS NSs. Thus, mNiS NSs have been demonstrated here to have potential as a novel NIR light-responsive hydrophobic drug delivery nanoplatform for realizing synergistic cancer treatment.
为了克服药物疏水性和癌症耐药性的不利影响,本文成功制备了介孔 NiS 纳米球(mNiS NSs)来包裹疏水性喜树碱(CPT),实现了癌症的协同光热-化学治疗。通过简便的溶剂热法制备的 mNiS NSs 不仅表现出相当大的近红外(NIR)吸收和高达 44.6%的良好光热转换效率,而且还实现了 NIR 光诱导的 CPT 释放性能,这都有利于提高癌细胞杀伤效果。当 4T1 或 HepG2 癌细胞用 CPT@mNiS NSs 孵育时,在短时间的 NIR 光照射后,观察到显著增强的细胞杀伤效果。因此,本文证明 mNiS NSs 具有作为新型 NIR 光响应性疏水药物递送纳米平台的潜力,可实现协同癌症治疗。